Methods In this multicenter, retrospective, propensity score-matched cohort study using the TriNetX US Collaborative Network, we compared outcomes in 43,743 new tirzepatide initiators versus 43,743 matched SGLT2i users with MASLD and 1 metabolic comorbidity
Jet Lag Disorder 2
Contributor Information Dilan Athauda, Email: [email protected]
Register and receive instant email notifications to track the status of HealthWells diverse portfolio of disease funds in real-time
doi: 10.1001/jama.2021.23619 Zhang P, Liu Y, Ren Y, Bai J, Zhang G, Cui Y
We performed live imaging of N2a cells expressing Go-Nt 7 -GFP or MGNC-Nt 7 -GFP during incubation with the depalmitoylation blocker Palmostatin B, an acyl protein thioesterase 1 and 2 inhibitor 26